Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

About Robert Duggan

Robert Duggan Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Robert Duggan News

The 5 biggest insider stock buys of last week

Jul 6, 2021

Companies include: Sprinklr, Bright Health Group, Pulse Biosciences, Asana, and Doximity. Two firms saw big purchases upon the closing date of their share offerings. Asana insiders continued their buying spree. Insider is watching which corporate executives are making big bets on their own companies. Here are the five companies that saw the biggest combined stock purchases from insiders during the period from June 24 through July 2, according to data compiled by Insider Monitor . 1. Sprinklr - $84,359,392 On June 25, at $16 per share, 10% owners Dharmesh Thakker, Neeraj Agrawal, and David Tabors each bought 1,073,731 shares of Sprinklr, amounting to $17,179,696 per transaction. Another 10% owner Divesh Makan bought 606,518 shares at a value of $9,704,288. H&F Splash Holdings IX, also a 10% owner, bought 1,413,501 shares, amounting to $22,616,016, while CEO Ragy Thomas bought 31,250 shares, totaling $500,000. Sprinklr, a customer experience software platform, announced the closing of its initial public offering on June 25. The company's Class A common stock is listed on the New York Stock Exchange. 2. Bright Health Group - $69,999,984 On June 28, 10% owners Edward Walker and Carmen Chang bought 1,944,444 shares at $18 per share, amounting to $34,999,992 apiece. The share offering of the healthcare company, which began trading on the New York Stock Exchange on June 24, closed on June 28 . Bright Health Group delivers virtual and in-person clinical care through 61 of its affiliated primary care clinics and offers Medicare and Commercial health plan products in 14 states and 99 markets. 3. Pulse Biosciences - $49,999,991 Chairman of the board Robert Duggan bought 3,048,780 shares at $16.40 each, amounting to $49,999,991, on June 30. The following day, the bioelectric medicine company announced that it has entered into a stock purchase agreement with Duggan. And as part of the private placement, Duggan, who owns approximately 46% of the company's outstanding common stock, will invest an additional $8.4 million as new capital. 4. Asana - $29,824,000 Dustin Moskovitz - president, CEO, and chairman of Asana - continued his buying spree by purchasing 480,000 shares in three tranches. On June 24, he bought 160,000 shares at $60.30, another 160,000 shares on June 25 at $62.86, and an additional 160,000 on June 30 at $63.24. For the week of June 17 to June 25, Moskovitz bought a total of $45,328,960 . The productivity startup Asana completed its direct listing in September 2020, giving it a valuation of $4.4 billion at that time. Currently, Asana boasts of an $11 billion market capitalization. 5. Doximity - $20,150,000 On June 28, Emergence GP Partners bought 775,000 shares at $26 each, amounting to $20,150,000. The share offering of the healthcare startup, which began trading on the New York Stock Exchange on June 24, closed on June 28 . Doximity, considered the " LinkedIn for Doctors ," has a current valuation of $8.4 billion. Its platform includes a newsfeed for healthcare updates and a search tool for job listings. Read the original article on Business Insider

Robert Duggan Investments

1 Investments

Robert Duggan has made 1 investments. Their latest investment was in Summit Therapeutics as part of their PIPE on January 1, 2019.

CBI Logo

Robert Duggan Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/14/2019

PIPE

Summit Therapeutics

$25M

Yes

2

Date

1/14/2019

Round

PIPE

Company

Summit Therapeutics

Amount

$25M

New?

Yes

Co-Investors

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.